BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 6397916)

  • 1. [Slow-Trasicor in the treatment of angina pectoris].
    Giec L; Trusz-Gluza M; Hübner D; Olwiński M
    Wiad Lek; 1984 Sep; 37(18):1401-6. PubMed ID: 6397916
    [No Abstract]   [Full Text] [Related]  

  • 2. [Multi-centric study of angina pectoris under oxprenolol treatment combined with nitrates in the Trivento region].
    Dalla Volta S; D'Amelio G
    Minerva Cardioangiol; 1980; 28(7-8):475-80. PubMed ID: 7005710
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical effect of oxprenolol in angina pectoris: comparison with a placebo and propranolol by double blind assay].
    Murakami M; Murakami E; Takekoshi J; Hayase S; Shintani H
    Nihon Rinsho; 1973 Apr; 31(4):913-22. PubMed ID: 4580401
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of clinical effects of propranolol (Inderal) with once daily slow-release oxprenolol (Slow Trasicor) in angina pectoris.
    Majid PA; de Feijter PJ; Wardeh R; van der Wall EE; Roos JP
    J Int Med Res; 1979; 7(3):194-200. PubMed ID: 378729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind clinical trial in angina pectoris. A comparison between oxprenolol, practolol and placebo.
    Forrest WA
    Br J Clin Pract; 1975 Dec; 29(12):343-6. PubMed ID: 764841
    [No Abstract]   [Full Text] [Related]  

  • 6. Slow release oxprenolol in angina pectoris [proceedings].
    Goldstraw PW; Taylor SH; Thadani U; Watt SJ
    Br J Clin Pharmacol; 1977 Jun; 4(3):387P. PubMed ID: 332219
    [No Abstract]   [Full Text] [Related]  

  • 7. A total of 254 cases of angina pectoris treated with oxprenolol in hospital practice--a monitored release study.
    Forrest WA
    Br J Clin Pract; 1972 May; 26(5):217-22. PubMed ID: 4625606
    [No Abstract]   [Full Text] [Related]  

  • 8. The use of Trasicor and hypothiazide in the treatment of hypertension and hypertensive angina pectoris.
    Antalóczy Z
    Ther Hung; 1975; 23(3):118-21. PubMed ID: 1209524
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical study of delayed-action oxprenolol in the treatment of angina pectoris. Apropos of 21 cases].
    Fournier D
    Lille Med; 1981; 26(1-2):62-4. PubMed ID: 7206997
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of angina pectoris with oxprenolol. Its evaluation with ergometric tests].
    Tormo Alfonso V; Velasco Rami JA; Serra Sister E; Mora Marti F
    Rev Clin Esp; 1978 Sep; 150(6):361-5. PubMed ID: 725180
    [No Abstract]   [Full Text] [Related]  

  • 11. Slow-Trasicor (sustained-release oxprenolol hydrochloride 160 mg) in the treatment of essential hypertension: a multicentre evaluation of 4,400 patients.
    Forrest WA
    Br J Clin Pract; 1977 Nov; 31(11):181-6. PubMed ID: 339937
    [No Abstract]   [Full Text] [Related]  

  • 12. Objective and subjective parameters in angina pectoris (effect of beta-receptor blockade).
    Shah SJ; Billimoria AR; Anand MP; Haveliwala HK; Vibhakar BB
    Indian Heart J; 1972 Oct; 24(4):337-41. PubMed ID: 4632392
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical evaluation of oxprenolol in angina pectoris.
    Sandler G; Pistevos A
    Br Heart J; 1972 Aug; 34(8):847-50. PubMed ID: 4560824
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of angina pectoris with Trasicor (CIBA 39089-Ba)].
    Lorenzen J
    Nord Med; 1970 Jun; 83(25):783-5. PubMed ID: 4393479
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug surveillance in general practice: a study of oxprenolol in the treatment of angina.
    Watt M
    N Z Med J; 1975 Feb; 81(534):200-2. PubMed ID: 1055941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The role of reduction of the heart rate in the favorable effect of the beta blockers on myocardial ischemia due to isoprenalin in patients with angina pectoris].
    Rivier JL; Monti M; Mazzoni S; Reymond C; Jaggi CP; Jaeger M
    Schweiz Med Wochenschr; 1977 Nov; 107(44):1555-6. PubMed ID: 918610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxprenolol in angina pectoris [proceedings].
    Taylor SH; Thadani U
    Br J Pharmacol; 1976 Nov; 58(3):412P. PubMed ID: 990603
    [No Abstract]   [Full Text] [Related]  

  • 18. Experience with a sustained-release formulation of oxprenolol in the management of angina pectoris in hospital out-patient departments.
    Forrest WA
    Curr Med Res Opin; 1978; 5(9):669-74. PubMed ID: 104825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Examination of the cardioprotective effect of Trasicor-80 in primary health care.
    Losonczy I; Fülep I; Kovács L
    Ther Hung; 1986; 34(3):175-7. PubMed ID: 2450409
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of hypertrophic cardiomyopathy with a delayed-action preparation of Trasicor].
    Dabrowski M; Bijak A; Letowski A; Rydlewska-Sadowska W; RuzyłłO W; Hoffman M
    Kardiol Pol; 1984; 27(7):579-89. PubMed ID: 6392686
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.